
Compounded Unapproved Drugs Linked to Three Horse Deaths
Rapid Equine Solutions compounded the product, which was labeled as containing toltrazuril and pyrimethamine for the treatment of EPM.
Rapid Equine Solutions compounded the product, which was labeled as containing toltrazuril and pyrimethamine for the treatment of EPM.
Renowned veterinarians talk catastrophic injury prevention, uniform medication policies, and more in a Translational Medicine Institute video.
Australian researchers recently tested whether velagliflozin could help prevent laminitis in horses, and they say it’s showing promising results in early trials.
Scientists found 200 E. coli strains, about half of which were resistant to at least one microbial agent, in manure, air, and horse nostrils at Polish riding centers. Here’s what that means for you.
Proposals for research on how bisphosphonates impact racehorses and young racing prospects intended for sale at public auction must be submitted by Oct. 1.
This gift will help the University of Kentucky launch a world-class equine drug research and testing program under the direction of Scott Stanley, PhD.
Many factors affect your horse’s ability to mount an effective immune response, one of which is his age. Learn more about the horse’s immune system and how it functions at every stage of his life.
Beginning Jan. 1, 2020, 2-year-olds would be prohibited from receiving furosemide within 24 hours of a race at coalition tracks. Beginning in 2021, the same prohibition would extend to all horses participating in any stakes race.
Recommendations include avoiding using bisphosphonates in manners inconsistent with indications of use on the label and discontinuing bisphosphonates use in any horses in training regardless of age, having every jurisdiction employ a full-time equine medical director, and more.
Officials from the Keeneland Association, Fasig-Tipton Company, and Ocala Breeders’ Sales Company announced they will enable buyers of horses younger than 4 years old to have those horses tested for bisphosphonates.
Bisphosphonates are FDA-approved for controlling clinical signs associated with navicular syndrome in horses ages 4 and older. Some veterinarians use them off-label to treat other equine bone issues. But could this off-label use be detrimental? One equine veterinarian recently gave a rundown on what research says.
Some products found on farms are flammable, toxic, or hazardous to human and animal health. Learn more about how to use, store, and discard them properly.
Complete veterinary-record transparency, strict limitations on pain-relieving and/or anti-inflammatory medication/treatment, and banning therapeutic medications or treatments without a qualified veterinary diagnosis from a state-licensed veterinarian are among the agreed-upon initiatives.
Researchers found that firocoxib and flunixin meglumine provided similar levels of pain control after colic surgery, but firocoxib resulted in reduced evidence of endotoxemia at 48 hours post-surgery.
Learn about the current challenges of medication regulation and drug testing in the race and sport horse industries.
Learn about veterinarians’ current understanding of navicular syndrome with these articles, downloads, videos, and more. Sponsored by Dechra Veterinary Products.
Stay on top of the most recent Horse Health news with
"*" indicates required fields